1. Executive summary |
2. Global Point-of-Care Diagnostics Market Introduction |
2.1. Global Point-of-Care Diagnostics Market – Taxonomy |
2.2. Global Point-of-Care Diagnostics Market –Definitions |
2.2.1. Product Type |
2.2.2. Prescription Mode |
2.2.3. End-User |
3. Global Point-of-Care Diagnostics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Point-of-Care Diagnostics Market Dynamics – Factors Impact Analysis |
3.6. Global Point-of-Care Diagnostics Market – Regulations |
3.6.1. U.S. |
3.6.2. Europe |
3.6.3. Japan |
3.7. Global Point-of-Care Diagnostics Market – Recent Product Innovations |
4. Global Point-of-Care Diagnostics Market Analysis, 2017-2021 and Forecast 2022-2028 |
4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Point-of-Care Diagnostics Market, By Product Type, 2017-2021 and Forecast 2022-2028 |
5.1. Infectious Disease Testing Kits |
5.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Cancer/Tumor Markers Testing |
5.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Cardio-Metabolic Monitoring Kits |
5.3.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Fertility and Pregnancy Testing Kits |
5.4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Hematological Testing Kits |
5.5.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Fecal Occult Testing Kits |
5.6.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Glucose Monitoring Kits |
5.7.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. Cholesterol Test Strips |
5.8.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Urinalysis Testing Kits |
5.9.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Others |
5.10.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
6. Global Point-of-Care Diagnostics Market, By Prescription Mode, 2017-2021 and Forecast 2022-2028 |
6.1. Over-the-Counter (OTC) Testing Kits |
6.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Prescription Based Testing Kits |
6.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Point-of-Care Diagnostics Market Forecast, By End-User, 2017-2021 and Forecast 2022-2028 |
7.1. Hospitals |
7.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centers |
7.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Homecare |
7.3.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Others |
7.4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Point-of-Care Diagnostics Market Forecast, By Region, 2017-2021 and Forecast 2022-2028 |
8.1. North America |
8.1.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2017-2021 and Forecast 2022-2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Point-of-Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Region, 2022 & 2028 |
9. North America Point-of-Care Diagnostics Market Analysis, 2017-2021 and Forecast 2022-2028 |
9.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Infectious Disease Testing Kits |
9.1.2. Cancer/Tumour Markers Testing |
9.1.3. Cardio-Metabolic Monitoring Kits |
9.1.4. Fertility and Pregnancy Testing Kits |
9.1.5. Haematological Testing Kits |
9.1.6. Faecal Occult Testing Kits |
9.1.7. Glucose Monitoring Kits |
9.1.8. Cholesterol Test Strips |
9.1.9. Urinalysis Testing Kits |
9.1.10. Others |
9.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Over-the-counter (OTC) Testing Kits |
9.2.2. Prescription-based Testing Kits |
9.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Hospitals |
9.3.2. Diagnostic Centers |
9.3.3. Homecare |
9.3.4. Others |
9.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. U.S. |
9.4.2. Canada |
9.5. North America Point-of-Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028 |
9.6. North America Point-of-Care Diagnostics Market Dynamics – Trends |
10. Europe Point-of-Care Diagnostics Market Analysis, 2017-2021 and Forecast 2022-2028 |
10.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Infectious Disease Testing Kits |
10.1.2. Cancer/Tumor Markers Testing |
10.1.3. Cardio-Metabolic Monitoring Kits |
10.1.4. Fertility and Pregnancy Testing Kits |
10.1.5. Hematological Testing Kits |
10.1.6. Fecal Occult Testing Kits |
10.1.7. Glucose Monitoring Kits |
10.1.8. Cholesterol Test Strips |
10.1.9. Urinalysis Testing Kits |
10.1.10. Others |
10.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Over-the-counter (OTC) Testing Kits |
10.2.2. Prescription-based Testing Kits |
10.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Hospitals |
10.3.2. Diagnostic Centers |
10.3.3. Homecare |
10.3.4. Others |
10.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Russia |
10.4.7. Poland |
10.4.8. Rest of Europe |
10.5. Europe Point-of-Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028 |
10.6. Europe Point-of-Care Diagnostics Market Dynamics – Trends |
11. Asia-Pacific Point-of-Care Diagnostics Market Analysis, 2017-2021 and Forecast 2022-2028 |
11.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Infectious Disease Testing Kits |
11.1.2. Cancer/Tumor Markers Testing |
11.1.3. Cardio-Metabolic Monitoring Kits |
11.1.4. Fertility and Pregnancy Testing Kits |
11.1.5. Hematological Testing Kits |
11.1.6. Fecal Occult Testing Kits |
11.1.7. Glucose Monitoring Kits |
11.1.8. Cholesterol Test Strips |
11.1.9. Urinalysis Testing Kits |
11.1.10. Others |
11.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Over-the-counter (OTC) Testing Kits |
11.2.2. Prescription-based Testing Kits |
11.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Hospitals |
11.3.2. Diagnostic Centers |
11.3.3. Homecare |
11.3.4. Others |
11.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), |
Y-o-Y Growth (%), and Market Share (%) |
11.4.1. Japan |
11.4.2. China |
11.4.3. India |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Point-of-Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028 |
11.6. Asia Pacific Point-of-Care Diagnostics Market Dynamics – Trends |
12. Latin America Point-of-Care Diagnostics Market Analysis, 2017-2021 and Forecast 2022-2028 |
12.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Infectious Disease Testing Kits |
12.1.2. Cancer/Tumor Markers Testing |
12.1.3. Cardio-Metabolic Monitoring Kits |
12.1.4. Fertility and Pregnancy Testing Kits |
12.1.5. Hematological Testing Kits |
12.1.6. Fecal Occult Testing Kits |
12.1.7. Glucose Monitoring Kits |
12.1.8. Cholesterol Test Strips |
12.1.9. Urinalysis Testing Kits |
12.1.10. Others |
12.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Over-the-counter (OTC) Testing Kits |
12.2.2. Prescription-based Testing Kits |
12.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Hospitals |
12.3.2. Diagnostic Centers |
12.3.3. Homecare |
12.3.4. Others |
12.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Argentina |
12.4.4. Venezuela |
12.4.5. Rest of Latin America |
12.5. Latin America Point-of-Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028 |
12.6. Latin America Point-of-Care Diagnostics Market Dynamics – Trends |
13. Middle East and Africa Point-of-Care Diagnostics Market Analysis, 2017-2021 and Forecast 2022-2028 |
13.1. Product Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Infectious Disease Testing Kits |
13.1.2. Cancer/Tumor Markers Testing |
13.1.3. Cardio-Metabolic Monitoring Kits |
13.1.4. Fertility and Pregnancy Testing Kits |
13.1.5. Hematological Testing Kits |
13.1.6. Fecal Occult Testing Kits |
13.1.7. Glucose Monitoring Kits |
13.1.8. Cholesterol Test Strips |
13.1.9. Urinalysis Testing Kits |
13.1.10. Others |
13.2. Prescription Mode Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Over-the-counter (OTC) Testing Kits |
13.2.2. Prescription-based Testing Kits |
13.3. End-User Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Hospitals |
13.3.2. Diagnostic Centers |
13.3.3. Homecare |
13.3.4. Others |
13.4. Country Analysis (2017 – 2017) and Forecast (2022 & 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. Israel |
13.4.3. South Africa |
13.4.4. Rest of MEA |
13.5. MEA Point-of-Care Diagnostics Market - Opportunity Analysis Index, By Product Type, Prescription Mode, End-User, and Country, 2022 & 2028 |
13.6. MEA Point-of-Care Diagnostics Market Dynamics – Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Siemens-Healthineers |
14.2.2. Abbott Laboratories, Inc. (U.S.) |
14.2.3. Koninklijke Philips N.V. (Netherlands) |
14.2.4. Becton, Dickinson, and Company (U.S.) |
14.2.5. Mologic Ltd (U.K.) |
14.2.6. Roche Diagnostics (U.S.) |
14.2.7. Nova Biomedical (U.S.) |
14.2.8. Beckman Coulter, Inc. (U.S.) |
14.2.9. Ngaio Diagnostics (New Zealand) |
15. Research Methodology |
16. Key Assumptions and Acronyms |